Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Resistance to rapamycin: A novel anticancer drug

  • Shile Huang
  • , Peter J. Houghton

Producción científica: Article › revisión exhaustiva

Resumen

The macrocyclic lactone rapamycin has an established place as an immune suppressive agent in organ transplantation. However, more recently it has been recognized as an inhibitor of pathways that may be activated during malignant transformation and tumor progression. Thus, increasing interest is being directed to this class of antibiotic as potential antitumor agents. Here we summarize the history, mechanism of action, and mechanisms of resistance to rapamycin.

Idioma originalEnglish (US)
Páginas (desde-hasta)69-78
Número de páginas10
PublicaciónCancer and Metastasis Reviews
Volumen20
N.º1-2
DOI
EstadoPublished - 2001
Publicado de forma externaSí

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Resistance to rapamycin: A novel anticancer drug'. En conjunto forman una huella única.

Citar esto